Soluble C-Met as a Biomarker of Clinical Outcomes After STEMI
Abstract
No abstract available
Journal Articles
Journal of the American College of Cardiology
Year : 2021
laboratoire CarMeN : Connect in order to contact the contributor
https://www.hal.inserm.fr/inserm-03344374
Submitted on : Wednesday, September 15, 2021-7:34:26 AM
Last modification on : Friday, September 30, 2022-10:58:10 AM
Long-term archiving on: Thursday, December 16, 2021-6:07:53 PM
Dates and versions
Identifiers
- HAL Id : inserm-03344374 , version 1
- DOI : 10.1016/j.jacc.2021.03.015
- PUBMED : 33958133
Cite
S. Leboube, A. Paccalet, C. C. da Silva, A. Hayek, F. Derimay, et al.. Soluble C-Met as a Biomarker of Clinical Outcomes After STEMI. Journal of the American College of Cardiology, 2021, 77 (18), pp.2348-2350. ⟨10.1016/j.jacc.2021.03.015⟩. ⟨inserm-03344374⟩
7
View
17
Download